These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 6895104

  • 1. The chemotherapy of C3H mice bearing Gardner lymphosarcoma with bovine fibrinogen-methotrexate derivative.
    Motycka K, Slavík K, Dyr JE, Balcarová A, Vodrázka Z.
    Neoplasma; 1981; 28(1):3-10. PubMed ID: 6895104
    [Abstract] [Full Text] [Related]

  • 2. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. II. Chemotherapy of Gardner lymphosarcoma with pea seed lectin-methotrexate derivative.
    Bures L, Motycka K, Bostík J, Slavík K, Jirásek A.
    Neoplasma; 1986; 33(4):409-16. PubMed ID: 3762803
    [Abstract] [Full Text] [Related]

  • 3. Organ distribution of fibrinogen-bound methotrexate in mice with Gardner lymphosarcoma.
    Slavíková V, Dyr JE, Motycka K, Pristoupilová K, Holý P, Slavík K.
    Neoplasma; 1987; 34(3):269-76. PubMed ID: 3614463
    [Abstract] [Full Text] [Related]

  • 4. Effect of free and bovine fibrinogen-bound methotrexate and dibromoaminopterin on the dissemination of solid Gardner lymphosarcoma.
    Motycka K, Dyr JE, Macáková A, Slavík K.
    Neoplasma; 1982; 29(2):197-204. PubMed ID: 6896744
    [Abstract] [Full Text] [Related]

  • 5. Effect of methotrexate sorbed on modified 2-hydroxyethylmethacrylate carriers in mice of C3H strain with a solid Gardner lymphosarcoma.
    Motycka K, Slavík, kocovská A, Cihar R, Spacek P, Kubín M.
    Neoplasma; 1977; 24(3):271-6. PubMed ID: 578291
    [Abstract] [Full Text] [Related]

  • 6. Distribution and pharmacokinetics of methotrexate in localized chemotherapy of solid Gardner's lymphosarcoma.
    Slavíková V, Motycka K, Slavík K, Spacek P, Cihar R, Balcarová A.
    Neoplasma; 1978; 25(2):211-6. PubMed ID: 580447
    [Abstract] [Full Text] [Related]

  • 7. Treatment of solid Gardner lymphosarcoma with methotrexate sorbed on 2-hydroxyethylmethacrylate polymer in combination with leukovorin.
    Motycka K, Slavík K, Balcarbová A, Cihar R, Spacek P, Kubín M.
    Neoplasma; 1978; 25(2):217-25. PubMed ID: 306074
    [Abstract] [Full Text] [Related]

  • 8. Localized chemotherapy of Gardner's lymphosarcoma of C3H mice using combinations of carrier-sorbed antifolics and detoxicating tetrahydrofolates.
    Motycka K, Slavík K, Balcarová A, Spacek P, Kubín M.
    Czech Med; 1981; 4(1-2):14-24. PubMed ID: 6973453
    [Abstract] [Full Text] [Related]

  • 9. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. III. Human serum albumin-methotrexate derivative, its preparation and basic testing.
    Bures L, Bostík J, Motycka K, Spundová M, Rehák L.
    Neoplasma; 1988; 35(3):329-42. PubMed ID: 3405341
    [Abstract] [Full Text] [Related]

  • 10. Treatment of C3H mice bearing solid Gardner lymphosarcoma with vaccine prepared from Corynebacterium parvum combined with methotrexate and Alexan.
    Motycka K, Chudomel V, Bednár M, Bostík J.
    Arch Immunol Ther Exp (Warsz); 1984; 32(4):413-9. PubMed ID: 6549500
    [Abstract] [Full Text] [Related]

  • 11. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. V. Alternative method for preparation of serum albumin-methotrexate derivative.
    Bures L, Lichý A, Bostík J, Spundová M.
    Neoplasma; 1990; 37(3):225-31. PubMed ID: 2370913
    [Abstract] [Full Text] [Related]

  • 12. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. IV. Therapy of murine melanoma B16 by human serum albumin-methotrexate derivative.
    Bostík J, Bures L, Spundová M.
    Neoplasma; 1988; 35(3):343-9. PubMed ID: 3405342
    [Abstract] [Full Text] [Related]

  • 13. Control of solid tumor metastases with a high-molecular-weight derivative of methotrexate.
    Chu BC, Whiteley JM.
    J Natl Cancer Inst; 1979 Jan; 62(1):79-82. PubMed ID: 281578
    [Abstract] [Full Text] [Related]

  • 14. Immunogenicity of the Gardner lymphosarcoma for the mice of the strain C3H (H-2k). II. Alteration of the growth and dissemination of solid Gardner lymphosarcoma following immunization by an extract of the ascitic tumor.
    Motycka K, Bostík J, Bures L, Slavík K, Jirásek A.
    Neoplasma; 1986 Jan; 33(2):177-85. PubMed ID: 3754937
    [Abstract] [Full Text] [Related]

  • 15. The effect of fibrinogen-methotrexate derivatives on HeLa cell growth.
    Dyr JE, Hermanová E, Slavík K, Vodrázka Z.
    Neoplasma; 1986 Jan; 33(4):401-7. PubMed ID: 3531894
    [Abstract] [Full Text] [Related]

  • 16. Changes in metabolism, food and water intake of C3H mice following transplantation of Gardner lymphosarcoma (LSG).
    Bostík J, Vybíral S, Spundová M.
    Physiol Bohemoslov; 1988 Jan; 37(4):325-32. PubMed ID: 2973618
    [Abstract] [Full Text] [Related]

  • 17. Effect of vaccine prepared from Corynebacterium parvum on the growth of Gardner lymphosarcoma in C3H strain mice.
    Motycka K, Chudomel V, Bednár M, Bostík J.
    Arch Immunol Ther Exp (Warsz); 1984 Jan; 32(4):405-12. PubMed ID: 6549499
    [Abstract] [Full Text] [Related]

  • 18. Changes in hemopoiesis of mice of the C3H strain following transplantation of Gardner lymphosarcoma and infection with LDH-virus. I. Circulating blood.
    Motycka K, Viktora L, Neuwirtová K, Balcarová A.
    Neoplasma; 1979 Jan; 26(5):551-8. PubMed ID: 583292
    [Abstract] [Full Text] [Related]

  • 19. Effect of the alpha globulin fraction on the survival time of C3H mice (C3H/Sumice and C3H/VUFB) with a solid Gardner lymphosarcoma.
    Motycka K, Bednarík T, Balcarová A.
    Folia Biol (Praha); 1980 Jan; 26(5):359-65. PubMed ID: 6160062
    [Abstract] [Full Text] [Related]

  • 20. Cytotoxic and antitumor effect of fibrinogen-methotrexate conjugate.
    Boratyński J, Opolski A, Wietrzyk J, Górski A, Radzikowski C.
    Cancer Lett; 2000 Feb 01; 148(2):189-95. PubMed ID: 10695996
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.